Volgen
Ymkje Stienstra
Ymkje Stienstra
tenure-track professor UMCG, Department of internal medicine/infectious diseases, Groningen, The
Geverifieerd e-mailadres voor umcg.nl - Homepage
Titel
Geciteerd door
Geciteerd door
Jaar
Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non–cystic fibrosis bronchiectasis: the BAT randomized controlled trial
J Altenburg, CS de Graaff, Y Stienstra, JH Sloos, EHJ van Haren, ...
Jama 309 (12), 1251-1259, 2013
5912013
Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial
WA Nienhuis, Y Stienstra, WA Thompson, PC Awuah, KM Abass, W Tuah, ...
The Lancet 375 (9715), 664-672, 2010
3422010
Mycobacterium ulcerans disease
TS van der Werf, Y Stienstra, RC Johnson, R Phillips, O Adjei, B Fleischer, ...
Bulletin of the World Health Organization 83, 785-791, 2005
2242005
Quality of interhospital transport of critically ill patients: a prospective audit
JJM Ligtenberg, LG Arnold, Y Stienstra, TS van der Werf, JHJM Meertens, ...
Critical Care 9, 1-6, 2005
2192005
Beliefs and attitudes toward Buruli ulcer in Ghana.
Y Stienstra, WTA van der Graaf, K Asamoa, TS van der Werf
The American journal of tropical medicine and hygiene 67 (2), 207-213, 2002
2182002
Risk Factors for Buruli Ulcer Disease (Mycobacterium ulcerans Infection): Results from a Case-Control Study in Ghana
PL Raghunathan, EAS Whitney, K Asamoa, Y Stienstra, TH Taylor Jr, ...
Clinical Infectious Diseases 40 (10), 1445-1453, 2005
2052005
Histopathologic features of Mycobacterium ulcerans infection
J Guarner, J Bartlett, EAS Whitney, PL Raghunathan, Y Stienstra, ...
Emerging infectious diseases 9 (6), 651, 2003
1912003
Paradoxical Responses After Start of Antimicrobial Treatment in Mycobacterium ulcerans Infection
WA Nienhuis, Y Stienstra, KM Abass, W Tuah, WA Thompson, PC Awuah, ...
Clinical infectious diseases 54 (4), 519-526, 2012
1272012
Mycolactones and Mycobacterium ulcerans disease
TS van der Werf, T Stinear, Y Stienstra, WTA van der Graaf, PL Small
The Lancet 362 (9389), 1062-1064, 2003
1172003
Susceptibility to development of Mycobacterium ulcerans disease: review of possible risk factors
Y Stienstra, WTA Van Der Graaf, GJ Te Meerman, TH The, LF De Leij, ...
Tropical Medicine & International Health 6 (7), 554-562, 2001
1102001
Susceptibility to development of Mycobacterium ulcerans disease: review of possible risk factors
Y Stienstra, WTA Van Der Graaf, GJ Te Meerman, TH The, LF De Leij, ...
Tropical Medicine & International Health 6 (7), 554-562, 2001
1102001
Variability of antibiotic susceptibility and toxin production of Staphylococcus aureus strains isolated from skin, soft tissue, and bone related infections
H Sina, TA Ahoyo, W Moussaoui, D Keller, HS Bankolé, Y Barogui, ...
BMC microbiology 13, 1-9, 2013
992013
Early atherosclerosis in systemic sclerosis and its relation to disease or traditional risk factors
ME Hettema, D Zhang, K de Leeuw, Y Stienstra, AJ Smit, CGM Kallenberg, ...
Arthritis research & therapy 10, 1-8, 2008
902008
Susceptibility to Buruli ulcer is associated with the SLC11A1 (NRAMP1) D543N polymorphism
Y Stienstra, TS Van Der Werf, E Oosterom, IM Nolte, WTA Van der Graaf, ...
Genes & Immunity 7 (3), 185-189, 2006
892006
Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial
RO Phillips, J Robert, KM Abass, W Thompson, FS Sarfo, T Wilson, ...
The Lancet 395 (10232), 1259-1267, 2020
872020
Factors associated with functional limitations and subsequent employment or schooling in Buruli ulcer patients
Y Stienstra, MHG van Roest, MJ van Wezel, IC Wiersma, IC Hospers, ...
Tropical Medicine & International Health 10 (12), 1251-1257, 2005
872005
Functional limitations after surgical or antibiotic treatment for Buruli ulcer in Benin
Y Barogui, RC Johnson, TS van der Werf, G Sopoh, A Dossou, ...
American Journal of Tropical Medicine and Hygiene 81 (1), 82, 2009
842009
Healthcare seeking behaviour for Buruli ulcer in Benin: a model to capture therapy choice of patients and healthy community members
AA Mulder, RP Boerma, Y Barogui, C Zinsou, RC Johnson, J Gbovi, ...
Transactions of the Royal Society of Tropical Medicine and Hygiene 102 (9 …, 2008
772008
Long term streptomycin toxicity in the treatment of Buruli ulcer: follow-up of participants in the BURULICO drug trial
S Klis, Y Stienstra, RO Phillips, KM Abass, W Tuah, TS van der Werf
PLoS Neglected Tropical Diseases 8 (3), e2739, 2014
762014
Cytokine responses to stimulation of whole blood from patients with Buruli ulcer disease in Ghana
BD Westenbrink, Y Stienstra, MG Huitema, WA Thompson, EO Klutse, ...
Clinical and Vaccine Immunology 12 (1), 125-129, 2005
732005
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20